A mucosal vaccine formulation against tuberculosis by exploiting the adjuvant activity of S100A4—A damage-associated molecular pattern molecule
Article in Vaccine (July 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in Vaccine (July 2024)
Article in International Immunopharmacology (July 2024)
Article in Frontiers in Tuberculosis (July 2024)